NEOG director granted 49,929 options, 19,386 shares at $6.19
Neogen Corporation (NEOG) reported an insider transaction by a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Neogen Corporation (NEOG) reported an insider transaction by a director. On 10/24/2025, the director acquired 19,386 shares of common stock at a $6.19 price and now holds 19,386 shares directly.
The filing also reports a grant of 49,929 stock options with a $6.19 exercise price, expiring on 10/24/2035. The options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) | 49,929 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 19,386 | $6.19 | $120K |
Footnotes (1)
- F1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did NEOG report on this Form 4?
What is the exercise price and expiration for the NEOG options?
How do the NEOG awards vest?
What is the insider’s relationship to NEOG?
Was this filed by one reporting person?
AI-generated analysis. How Rhea-AI works. Not financial advice.